GOED released its annual Global EPA and DHA Omega-3 Ingredient Market Report
According to the report, volume EPA and DHA omega-3s increased 2.1% last year (2021), while the value of omega-3 ingredients increased 5.5% to $1.53 billion.
Photo © iStockphoto.com/ evemilla
The Global Organization for EPA and DHA Omega-3s (GOED) published the 2022 edition of its annual Global EPA and DHA Omega-3 Ingredient Market Report, detailing the raw materials segment of the EPA and DHA omega-3 industry, which was a 115,031 metric tons market in 2021. Volume increased 2.1% last year, while the value of omega-3 ingredients increased 5.5% to $1.53 billion. The industry is projected to reach 121,266 metric tons by 2024 at an average annual growth rate of 1.8% globally.
The report includes market figures for 14 omega-3 sources in 11 geographies, as well as six end-product applications that include dietary supplements, pharmaceuticals, infant formula, food and beverage, pet food, and clinical nutrition. Over 100 charts and tables detail the volume and value of omega-3 sources, regions, and end-product applications in 2021, with forecasts through 2024. New to this year’s report is the “at a glance” charts in each section and a set of PowerPoint slides with key market figures for companies to include in market presentations. These new features help companies navigate all the information provided by the report. There is also an Excel document with raw data and a forecast generator tool.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
